THE INTERNATIONAL GENOMICS CONSORTIUM (EIN 861024333) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2001

Legal Domicile

Principal Officer

DAVID MALLERY

Phone

6028507000

Tax Period

2023-01-01 to 2023-12-31

THE INTERNATIONAL GENOMICS CONSORTIUM, founded in 2001, is a micro nonprofit in the Medical Research sector that reported $84K in total revenue in fiscal year 2023. Revenue fell 71% from the prior year — a significant decline worth monitoring. Expenses of $1.4M exceeded revenue, resulting in a 1584% operating deficit.

Mission

WORK TO REVOLUTIONIZE THE TREATMENT AND PREVENTION OF CANCER AND COMPLEX DISEASES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $761

Investment Income $29

Other Revenue $83,112

TOTAL REVENUE $83,902

Expense Breakdown

Grants Paid $0

Salaries & Benefits $910,822

Fundraising Expenses $0

Program Expenses $674,361

Other Expenses $502,349

TOTAL EXPENSES $1,413,171

Year-over-Year Comparison

	2023	2022	Change
Revenue	$83,902	$294,190	-0.7%
Expenses	$1,413,171	$1,516,541	-0.1%
Net Income	$-1,329,269	$-1,222,351	+0.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$912,399

Total Directors

$666,981

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DAVID MALLERY	CEO	32.00	Officer Director	$600,000	$63,981	$663,981
TROY SHELTON	BOARD MEMBER	0.50	Director	$3,000	$0	$3,000
SCOTT MORRIS	CSO	24.00	Officer	$141,158	$36,451	$177,609
VANESA ROMERO	CFO	16.00	Officer	$40,404	$30,405	$70,809

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$83,902	$1,413,171	$10,812,620	$-1,329,269
2022	$294,190	$1,516,541	$10,251,570	$-1,222,351
2021	$3,350,681	$2,004,244	$13,871,737	$1,346,437
2020	$14,905,841	$1,983,807	$18,148,841	$12,922,034
2019	$2,383,718	$1,555,280	$4,615,825	$828,438
2018	$2,449,951	$1,426,782	$4,286,362	$1,023,169

THE INTERNATIONAL GENOMICS CONSORTIUM